We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Read more about cookies

an image
  • Register
  • Log in
  • Language

05 Feb Zurich

Life science: meet investors and big pharma/diagnostics companies

The Nordic countries in cooperation with Swiss partners welcome you to participate in an exclusive investment and partnering meeting, gathering executives from biotech, pharmaceutical, medtech and diagnostics companies as well as investors from Switzerland and the Nordic countries.

Investors

  • MS Ventures
  • Seventure Partner
  • Bay City Capital
  • Roche Venture Fund
  • Novartis Venture Fund
  • Sunstone Capital
  • Creathor Venture
  • Novo Seeds
  • Aravis
  • Endeavour Vision

Pharma / Diagnostics

  • Roche
  • Novartis
  • Pfizer
  • Takeda
  • MSD
  • Tillotts Pharma
  • Roche Diagnostics

Why SSBBS?

  • >15 investors and >10 scouting / business development executives from pharma/diagnostics companies expected
  • Switzerland and the Nordics are homes of some of the most innovative life science companies globally
  • Similarities in technology and R&D standards as well as business culture
  • Switzerland hosts several leading pharmaceutical companies and life science focused investors
  • Statistics show a large potential for R&D collaboration between SME, large corporations and academia within EUREKA-Eurostars.

For more information and registration see www.ssbbs2015.com